迪哲医药-U
(688192)
| 流通市值：261.51亿 | | | 总市值：263.75亿 |
| 流通股本：4.61亿 | | | 总股本：4.65亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 223,697,092.71 | 291,421,638.08 | 1,014,759,565.63 | 1,244,565,866.2 |
| 交易性金融资产 | 1,710,537,753.97 | 1,644,839,627.4 | 911,552,110.79 | 1,006,143,043.86 |
| 应收票据及应收账款 | 170,989,694.34 | 143,440,599.62 | 127,104,789.58 | 82,138,364.53 |
| 应收账款 | 170,989,694.34 | 143,440,599.62 | 127,104,789.58 | 82,138,364.53 |
| 预付款项 | 42,960,497.8 | 47,292,165.57 | 31,168,796.15 | 26,668,186.35 |
| 其他应收款合计 | 3,367,119.49 | 3,310,807.23 | 3,317,807.23 | 3,341,912.44 |
| 存货 | 32,136,513.01 | 36,949,433.77 | 38,543,896.97 | 40,547,178.15 |
| 其他流动资产 | 22,640,274.84 | 15,422,875.04 | 759,254.12 | 1,522,475.25 |
| 流动资产合计 | 2,206,328,946.16 | 2,182,677,146.71 | 2,127,206,220.47 | 2,404,927,026.78 |
| 非流动资产: | | | | |
| 固定资产 | 337,672,422.35 | 341,329,030.91 | 17,982,197.35 | 17,973,029.66 |
| 在建工程 | - | - | 311,586,203.09 | 283,305,976.64 |
| 使用权资产 | 38,045,727.51 | 39,902,079.85 | 45,698,288.26 | 41,535,501.37 |
| 无形资产 | 388,159,547.1 | 396,432,632.34 | 404,705,717.54 | 412,980,312.94 |
| 长期待摊费用 | 3,268,230.82 | 4,094,142 | 3,888,437.61 | 5,055,686.64 |
| 其他非流动资产 | 39,544,833.04 | 38,094,156.6 | 44,279,558.19 | 52,683,051.28 |
| 非流动资产合计 | 806,690,760.82 | 819,852,041.7 | 828,140,402.04 | 813,533,558.53 |
| 资产总计 | 3,013,019,706.98 | 3,002,529,188.41 | 2,955,346,622.51 | 3,218,460,585.31 |
| 流动负债: | | | | |
| 短期借款 | 108,954,708.38 | 217,453,428.33 | 247,861,661.61 | 359,939,606.82 |
| 应付票据及应付账款 | 157,712,776.75 | 211,840,307.78 | 197,697,282.25 | 164,657,570.66 |
| 应付账款 | 157,712,776.75 | 211,840,307.78 | 197,697,282.25 | 164,657,570.66 |
| 合同负债 | 6,848,571.48 | 5,504,596.1 | 6,542,645.09 | 7,678,449.47 |
| 应付职工薪酬 | 47,285,574.25 | 98,548,926.42 | 107,254,437.43 | 87,668,400.72 |
| 应交税费 | 24,253,663.91 | 18,514,894.02 | 12,457,051.67 | 8,846,372.64 |
| 其他应付款合计 | 85,520,501.92 | 120,201,862.94 | 112,148,289.13 | 128,755,545.42 |
| 一年内到期的非流动负债 | 351,782,741.36 | 313,170,079.69 | 177,959,303.32 | 130,654,318.03 |
| 流动负债合计 | 782,358,538.05 | 985,234,095.28 | 861,920,670.5 | 888,200,263.76 |
| 非流动负债: | | | | |
| 长期借款 | 966,141,996.69 | 688,146,996.69 | 612,360,118.14 | 660,814,178.14 |
| 租赁负债 | 19,247,146.88 | 21,981,276.28 | 23,965,349.6 | 26,542,814.74 |
| 递延收益 | 10,091,210.28 | 11,475,971.65 | 13,367,041.97 | 14,125,803.33 |
| 非流动负债合计 | 995,480,353.85 | 721,604,244.62 | 649,692,509.71 | 701,482,796.21 |
| 负债合计 | 1,777,838,891.9 | 1,706,838,339.9 | 1,511,613,180.21 | 1,589,683,059.97 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 464,633,342 | 461,187,894 | 459,412,894 | 459,412,894 |
| 资本公积 | 4,988,987,178.44 | 4,956,240,454.86 | 4,920,493,756.32 | 4,901,627,087.15 |
| 未分配利润 | -4,219,128,001.12 | -4,123,570,645.61 | -3,939,468,933.87 | -3,736,881,278.44 |
| 归属于母公司股东权益合计 | 1,234,492,519.32 | 1,293,857,703.25 | 1,440,437,716.45 | 1,624,158,702.71 |
| 少数股东权益 | 688,295.76 | 1,833,145.26 | 3,295,725.85 | 4,618,822.63 |
| 股东权益合计 | 1,235,180,815.08 | 1,295,690,848.51 | 1,443,733,442.3 | 1,628,777,525.34 |
| 负债和股东权益合计 | 3,013,019,706.98 | 3,002,529,188.41 | 2,955,346,622.51 | 3,218,460,585.31 |
| 公告日期 | 2026-04-30 | 2026-03-31 | 2025-10-31 | 2025-08-23 |
| 审计意见(境内) | | 标准无保留意见 | | |